Moclobemide, a new reversible MAO inhibitor — interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF00652232PMID 3081926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiocirculatory effects of moclobemide (Ro 11-1163), a new reversible, a short-acting MAO-inhibitor with preferential Type A inhibition, in healthy volunteers and depressive patients

  2004cited by this paper
• Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure

  1983cited by this paper
• Will amitriptyline prevent the ???cheese??? reaction of monoamine oxidase inhibitors?

  1983cited by this paper
• Tranylcypromine isomers in depressed outpatients: effects on depression, monoamine oxidase inhibition and tyramine pressor response.

  1983cited by this paper
• Will amitriptyline prevent the "cheese" reaction of monoamine-oxidase inhibitors?

  1982cited by this paper
• Antidepressant effect of Ro 11-1163, a new MAO inhibitor.

  1982cited by this paper
• Combined MAOI-tricyclic antidepressant treatment: a reevaluation.

  1981cited by this paper
• Inhibition of monoamine oxidase in man by furazolidone

  1968cited by this paper
• Hypertensive Interactions Between Monoamine Oxidase Inhibitors and Foodstuffs

  1967cited by this paper
• MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.

  1964cited by this paper
• Monoamine Oxidase Inhibitors, Tyramine, and Cheese

  1964cited by this paper

• Mitochondrial Peroxiredoxins and Monoamine Oxidase-A: Dynamic Regulators of ROS Signaling in Cardioprotection.

  2024cites this paper
• Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer’s and Parkinson’s Diseases

  2023cites this paper
• The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.

  2022cites this paper
• The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases

  2020cites this paper
• Synthesis and Structure Activity Relationship of Thiazolyl Hydrazones as Monoamine Oxidase Inhibitors: An Overview

  2018cites this paper
• A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths

  2018cites this paper
• Future Strategies for the Treatment of Depression

  2016cites this paper
• Monoamine-oxidase inhibitors: pharmacological profile

  2011cites this paper
• Advances Pertaining to the Pharmacology and Interactions of Irreversible Nonselective Monoamine Oxidase Inhibitors

  2011influential citation
• Polypharmazie in der Behandlung depressiver Störungen

  2009cites this paper
• Systematic Overview of Drug Interactions with Antidepressant Medications

  2006cites this paper
• Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers

  2005influential citation
• Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects

  2005cites this paper
• Oral tyramine pressor test and the safety of MAO inhibitor drugs

  2004cites this paper
• Nicht-selektive Monoamin- Rückaufnahme-Inhibitoren (NSMRI)

  2002cites this paper
• Monoamin-Oxidase-Hemmer

  2002cites this paper
• Food and Drug Interactions with Monoamine Oxidase Inhibitors

  1996cites this paper
• [Combination therapies in antidepressive drug refractory depression--an overview].

  1996cites this paper
• [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].

  1996cites this paper
• Clinical Pharmacokinetics of the Monoamine Oxidase-A Inhibitor Moclobemide

  1995cites this paper
• The behavioral toxicity of reversible inhibitors of monoamine oxidase A: laboratory and clinical investigations.

  1995cites this paper
• Comparative Tolerability Profiles of the Newer versus Older Antidepressants

  1994cites this paper
• New antidepressants: use in high-risk patients.

  1993cites this paper
• Verträglichkeitsaspekte der selektiven MAO-A-Hemmer unter besonderer Berücksichtigung der Interaktion mit Tyramin und Antidepressiva

  1993cites this paper
• Moclobemide overdose

  1993cites this paper
• Third‐generation antidepressants

  1993cites this paper
• The new generation of monoamine oxidase inhibitors.

  1992cites this paper
• UNALTERED IBUPROFEN-INDUCED FAECAL BLOOD LOSS UPON COADMINISTRATION OF MOCLOBEMIDE

  1992cites this paper
• Monoamine oxidase inhibitors: reversible and irreversible.

  1992cites this paper
• Moclobemide

  1992cites this paper
• Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase‐A inhibitor, and oral tyramine in healthy subjects

  1992cites this paper
• Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitor

  1991cites this paper
• Monoamine oxidase inhibitors: clinical review.

  1990cites this paper
• Disposition Kinetics of Moclobemide, a New Mao‐A Inhibitor, in Subjects with Impaired Renal Function

  1990cites this paper
• [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].

  1989cites this paper
• A Comparison of Moclobemide and Imipramine in Treatment of Depression

  1989cites this paper
• [Moclobemide in the long-term treatment of depressed patients].

  1989cites this paper
• Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.

  1989cites this paper
• Biochemical Aspects of the Pharmacology of Moclobemide

  1989cites this paper
• INTERACTION BETWEEN MOCLOBEMIDE AND ORAL TYRAMINE IN DEPRESSED PATIENTS

  1989cites this paper
• An overview of investigational antidepressants.

  1989cites this paper
• Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.

  1989cites this paper
• Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors.

  1989cites this paper
• Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers

  1989cites this paper
• Effect of Moclobemide, a New Reversible Monoamine Oxidase Inhibitor, on Absorption and Pressor Effect of Tyramine

  1988cites this paper
• Basic and clinical aspects of the activity of the new monoamine oxidase inhibitors.

  1988cites this paper
• Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects.

  1988cites this paper
• Disposition kinetics of moclobemide, a monoamine oxidase‐A enzyme inhibitor: Single and multiple dosing in normal subjects

  1987cites this paper